Table 1.
AIMed | BioInfer | HPRD50 | IEPA | LLL | ||
size | 1955 | 1100 | 145 | 486 | 77 | |
Entity | scope | human P/G | P/G/R and related | human P/G | Chemicals | P/G |
coverage | all occurrences | all occurrences | NER system | list of 16 names | list of 116 names | |
types | no | 111 types (ontology) | no | no | P/G | |
PPI | types | no | 68 types (ontology) | no | no | 3 types |
binding | no | yes | no | yes | no | |
directed | no | yes | no | yes | yes | |
complex | no | yes | no | no | no | |
negative | no | yes | no | no | no | |
certainty | no | no | yes | no | no |
Legend:
Size: Number of sentences in the corpus
Entity scope: Types of the named entities identified in the corpus: (P)rotein, (G)ene, (R)NA
Entity coverage: Coverage of in-scope entity occurrences in each sentence
Entity types: Explicit identification of the type of the annotated named entity occurrences
PPI types: Explicit indication of the type of the annotated interactions
PPI binding: Identification of the specific text spans that entail the annotated interactions
PPI directed: Specification of the directionality of the interaction (typically identification of agent vs. patient roles)
PPI complex: Annotation includes nested or n-ary (for n > 2) interactions
PPI negative: Annotation of negative interactions
PPI certainty: Annotation of the levels of certainty, or speculativeness, of interactions